These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 19949262)

  • 21. [Absolute risk for fracture and WHO guideline. WHO model for assessing absolute risk of fracture].
    Iki M;
    Clin Calcium; 2007 Jul; 17(7):1015-21. PubMed ID: 17607067
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Criteria for initiation of pharmacological treatment by Japanese 2011 guidelines for prevention and treatment of osteoporosis].
    Hagino H
    Clin Calcium; 2014 Mar; 24(3):339-47. PubMed ID: 24576930
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Osteoporosis - whom to treat? The importance of FRAX® in Switzerland].
    Lippuner K
    Ther Umsch; 2012 Mar; 69(3):207-13. PubMed ID: 22403115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A personal perspective on fracture risk assessment tools.
    Ettinger B
    Menopause; 2008; 15(5):1023-6. PubMed ID: 18703988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of the primary care physician in diagnosis and management of osteoporosis.
    Wehren LE
    Int J Fertil Womens Med; 2002; 47(3):116-22. PubMed ID: 12081256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Diagnosis and treatment of postmenopausal osteoporosis and osteoporosis in men. German Guidelines Update 2006].
    Kurth AA; Pfeilschifter J
    Orthopade; 2007 Jul; 36(7):683-90; quiz 691. PubMed ID: 17605128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [FRAX--model for 10-year fracture risk assessment. Support in the treatment of osteoporosis, according to preliminary Swedish guidelines].
    Johansson H; Kanis JA; Ljunggren O; Ström O; Svensson O; Mellström D
    Lakartidningen; 2011 Feb 16-22; 108(7):336-9. PubMed ID: 21539116
    [No Abstract]   [Full Text] [Related]  

  • 28. Bone mineral density measurement and treatment for osteoporosis in older individuals with fractures: a gap in evidence-based practice guideline implementation.
    Feldstein A; Elmer PJ; Orwoll E; Herson M; Hillier T
    Arch Intern Med; 2003 Oct; 163(18):2165-72. PubMed ID: 14557214
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How to decide who to treat.
    Kanis JA; McCloskey EV; Johansson H; Strom O; Borgstrom F; Oden A
    Best Pract Res Clin Rheumatol; 2009 Dec; 23(6):711-26. PubMed ID: 19945684
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening for osteoporosis in the adult U.S. population: ACPM position statement on preventive practice.
    Lim LS; Hoeksema LJ; Sherin K;
    Am J Prev Med; 2009 Apr; 36(4):366-75. PubMed ID: 19285200
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of women at increased risk of osteoporosis: no need to use different screening tools at different ages.
    Dargent-Molina P; Piault S; Bréart G
    Maturitas; 2006 Apr; 54(1):55-64. PubMed ID: 16202546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [FRAX: a new instrument for calculating 10-year absolute fracture risk].
    Claus-Hermberg H; Bagur A; Messina OD; Negri AL; Schurman L; Sánchez A
    Medicina (B Aires); 2009; 69(5):571-5. PubMed ID: 19897447
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bazedoxifene reduces vertebral and clinical fractures in postmenopausal women at high risk assessed with FRAX.
    Kanis JA; Johansson H; Oden A; McCloskey EV
    Bone; 2009 Jun; 44(6):1049-54. PubMed ID: 19254788
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Defining bone health and fracture risk in West Virginia: the World Health Organization FRAX assessment tool.
    Shuler FD; Conjeski J
    W V Med J; 2011; 107(5):12-7. PubMed ID: 22034804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New guidelines for the prevention and treatment of osteoporosis.
    Lewiecki EM; Watts NB
    South Med J; 2009 Feb; 102(2):175-9. PubMed ID: 19139693
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Do current management strategies and guidelines adequately address fracture risk?
    McClung MR
    Bone; 2006 Feb; 38(2 Suppl 2):S13-7. PubMed ID: 16403495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Osteoporosis disease management for fragility fracture patients: new understandings based on three years' experience with an osteoporosis care service.
    Harrington JT; Lease J
    Arthritis Rheum; 2007 Dec; 57(8):1502-6. PubMed ID: 18050169
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of fracture risk.
    Kanis JA; Johansson H; Oden A; McCloskey EV
    Eur J Radiol; 2009 Sep; 71(3):392-7. PubMed ID: 19716672
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of clinical risk factors in elderly women with low bone mineral density to identify women at higher risk of hip fracture: The EPIDOS prospective study.
    Dargent-Molina P; Douchin MN; Cormier C; Meunier PJ; Bréart G;
    Osteoporos Int; 2002 Jul; 13(7):593-9. PubMed ID: 12111021
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FRAX and the assessment of the risk of developing a fragility fracture.
    Middleton RG; Shabani F; Uzoigwe CE; Shoaib A; Moqsith M; Venkatesan M
    J Bone Joint Surg Br; 2012 Oct; 94(10):1313-20. PubMed ID: 23015554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.